Antoine A. | Founder & Managing Director of Segenic
09 May 2023 | Class: Partnerships | Category: Case Studies
Table of Contents
Abstract
This case study tracks one of our collaborative partner clinics across a span of 90 consecutive days, illuminating how astute ad spend allocation can result in statistically significant and traceable profit.
Like most others in the industry, prior to working with us, the partner case at issue, has been grappling with the seemingly daunting task of not only generating high-calibre leads, but also converting them into paying customers. Also, retaining them through efficient, client nurturing and relationship management strategies.
An evidently ubiquitous problem which is often the proverbial thorn in the side of many private clinics.
Moreover, as the intense rivalry escalates across the medical landscape, those clinics who fail to establish a digital stronghold will be surpassed and driven into extinction, uncannily reminiscent of the selective pressure that governs evolutionary biology.
Conversely, by employing the PAICC(vN) methodology’s inherent scientific precision and empirical rigour, this issue is tackled head-on. Thus, making our partner clinics both resolutely proficient and robustly adaptable, which in turn, allows them to take their rightful place as extinction-proof, apex species within the ever-transforming digital ecosystem.
The methodology employed was PAICCv5.4, being the most up-to-date version of our PAICC(vN) system at the time.
The duration was 3 months, or approx. 90 days in total.
The result was statistically significant (p-value ≤ 0.017) at 780% ROAS (7.8x) equating to £58,502 with £7,503 in ad spend. Additionally, as a by-product of this campaign, we grew our partner’s contact list by 18%.
Introduction
Successfully navigating the transition from preliminary online interest to established patient relationships, is a problem which continues to perplex countless private clinics.
Our featured partner for this case study, operates in the competitive field of regenerative medicine, offering innovative therapeutics such as Platelet-Rich Plasma (PRP), Hyaluronic Acid injections and Stem Cell therapy, among an array of other proprietary treatments.
Despite their laudable medical expertise, the clinic, like many others in this sphere, found itself entangled in the intricate web of patient acquisition, service delivery and client fulfilment.
Upon preliminary discussions with the clinic’s persons of significant control, we drafted a schema for the most efficient route to growth. Where Facebook, due to confidential client-related variables undisclosed in this study, was deemed the primary starting platform.
The assorted ad campaigns were mediated jointly by Facebook plus Messenger, and encompassed a multitude of clinic locations, with the ultimate goal of amplifying client acquisition, long-term patient retention and a sustained increase in sales.
Partner Case
Our partner, to whom this case study is dedicated, is a specialised private clinic which helps patients with both chronic and acute skeletomuscular dysfunction.
They’ve been investing heavily in advanced treatment modalities, ensuring that their health professionals are always armed with state-of-the-art medical equipment, novel APIs and the technical knowledge necessary to manage everything correctly.
Inferring from our in-person observation, their therapeutic arsenal is explicitly cordon bleu.
Alas, the clinic has been unremittingly grappling with the challenge of customer acquisition. They’ve faced considerable difficulties in attracting and retaining a steady stream of patients.
Evidently, this is a profound impediment to the clinic’s financial growth and long-term sustainability. Their premier services and undoubted commitment to patient care are commendable, yet without a reliable influx of new customers, the clinic’s potential remains unfulfilled.
The need to overcome this acquisition challenge and optimise their patient flow has become an essential strategic objective, requiring a robust solution that can address this matter with both precision and efficacy.
For this reason, we partnered and immediately began deploying the PAICCv5.4 system, being the most up-to-date version at the time.
The duration of this case study was 3 months, or approx. 90 days in total.
The result was statistically significant (p-value ≤ 0.017) at 780% ROAS (7.8x) equating to £58,502 with £7,503 in ad spend. Additionally, as a by-product of this campaign, we grew our partner’s contact list by 18%.
Objectives
We always look to establish measurable and tangible objectives, achievable within the mutually agreed upon preset timeframe.
Our partner clinic, at issue, was striving to increase their monthly revenue but couldn’t do so, due to rather peculiar operational impediments undisclosed in this case study.
For this reason, we met with their management and discussed the problem, the possible solutions and their long term vision at length.
The evident issue was the lack of qualified leads, which in turn, resulted in a low intake of patients.
Therefore, the objective was to implement the PAICCv5.4 system in order to rapidly remedy the problem by generating motivated leads, double qualifying and subsequently converting them into paying patients.
We agreed that any collateral benefits such as augmenting their online reputation and expanding their aggregate cyberspace presence, are welcomed ancillaries but aren’t the cardinal aim.
As per protocol, we meticulously forecasted their potential profits, and aligned them with our purely performance-based pricing structure, in a way which creates a categoric win-win-win scenario.
The patient wins first because they’re getting efficacious therapeutics, our client wins second as they are getting new patients, making more sales and saving an inordinate amount of time due to the autopilot nature of our PAICC(vN) system, and we win at the end by taking a small percentage of our client’s profit.
We quantified our mutual weekly and monthly goals accordingly and began integrating our partner clinic’s existing data set into our PAICCv5.4 system.
Methodology
Our patent-pending PAICC(vN) system, follows a rolling-release protocol, i.e. it is subject to regular, incremental updates, and at isochronous intervals, significant codebase and infrastructural advancements.
At the outset of this case study, the most up-to-date version of our system was PAICCv5.4. Therefore, that was the methodology employed to rapidly deliver the herein mentioned results.
The PAICC(vN) system, as explained in other parts of our website, is a finely-tuned multipronged, machine which merges both people and software together, to deliver factually unparalleled results.
A truly inimitable mechanism, which from our partners’ point of view, brings new qualified patients to their door, each month, on full autopilot. In parallel, it provides a vivid panoptic view of the entire customer journey, from the very first point of interest to the closing sale.
We’ve been building and improving upon the PAICC(vN) system for the best part of the last 4 years. And the latest version is always markedly better than past releases. Hence, our partners perpetually benefit from an evermore lean, effective and powerful, patient-procuring experience.
Outcomes
The result was statistically significant (p-value ≤ 0.017) at 780% ROAS (7.8x) and a total of £58,502 in revenue with £7,503 ad spend.
Equalling an average of £2,501 ad spend/month and £19,501 in ROAS/month. Even after the average baseline monthly profit.
Consequently, as a collateral benefit of this PAICCv5.4 implementation, we grew our partner clinic’s contact list by 18%. A noteworthy accrual of motivated subscribers, which in turn, evidently amplifies the effectiveness of all future standalone campaigns, or omnichannel initiatives.
As revealed below, a total of 528 ad clicks at £14.21 CPC and 1.55% CTR generated approximately 94 ardently-motivated leads which were further-double qualified and some disqualified via the PAICCv5.4 system. Those that qualified were later booked into our partner’s calendar and purchased one or more of their high ticket treatment modalities.
The outcome was £58,502 in revenue at 780% ROAS. However, it remains indispensable to clarify that standalone ad campaigns are incapable of delivering such landmark revenue targets coupled with such high profit margins.
The ad campaigns and/or the other assorted, async, digital leadgen modalities we employ, constitute solely the forward-facing part of our PAICC(vN) system.
The remaining 85% comprises an intricate amalgamation of specialised, bespoke back-end software plus raw human resource and data intelligence, enabling us to deliver factually unparalleled results with precision akin to molecular clockwork.
Moreover, as an adjunct benefit to this front-facing PAICCv5.4 campaign, the concurrently generated 34,000 impressions, produced objectively significant social visibility, propelling our partner clinic’s brand to a new elevated plane of cyber awareness.
Yet, irrespective of the varying success magnitudes each PAICC(vN) deployment attains, they all constitute a fertile ground for constructive feedback and a wellspring from which we draw inferential data, factual corollaries and analytical verdicts, specific to the partner case at issue. As a result, every successive deployment of PAICC(vN) is not merely a repetition, but a marked elevation.
Conclusion
This case study underscores the transformative potency of astute top funnel ad spend allocation as a part of the PAICC(vN) system, thus significantly augmenting our partner clinic’s profit trajectory.
Culminating in a noteworthy 780% ROAS, and converting an investment of £7,503 into £58,52 underpinned by (p-value ≤ 0.017) statistical significance.
Prior impediments, often the proverbial thorn in the side of many private clinics, such as high-quality lead generation, conversion and client retention, were wholly subjugated using the PAICC(vN) framework.
All of which validates the PAICC(vN) system as the vanguard of patient acquisition that allows our partner clinics to perpetually maintain a 5-step forward gap between them and their competition.
Resolutely proficient and robustly resilient, equipped with uncontested tactical supremacy, our partners are propelled towards market ascendency whilst being utterly undeterred by the current fiercely competitive medical milieu.
